According to an official WeChat post by Abbott on February 20, Abbott and China National Medical Device Co., Ltd. signed a strategic cooperation agreement. The two parties will promote comprehensive strategic cooperation in five key areas: distribution business, logistics platforms, after-sales services, digitalization, and medical education. This collaboration aims to enhance the accessibility of advanced life science technologies and smart healthcare solutions in China, including those for diagnostics, cardiovascular care, and diabetes management.

